Eaton Vance Management’s Novavax NVAX Stock Holding History

Eaton Vance Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-450	Closed	-$64K	–	2407
2021 Q4	$64K	Buy	450 +124	+38%	+$21.3K	﹤0.01%	2010
2021 Q3	$0	Buy	326 +1	+0.3%	+$220	﹤0.01%	2464
2021 Q2	$69K	Buy	325 +50	+18%	+$9.16K	﹤0.01%	2047
2021 Q1	$50K	Buy	+275	New	+$54.8K	﹤0.01%	1794
2016 Q3	–	Sell	-735	Closed	-$107K	–	978
2016 Q2	$107K	Sell	735 -400	-35%	-$45.8K	﹤0.01%	940
2016 Q1	$117K	Buy	+1,135	New	+$122K	﹤0.01%	920

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Eaton Vance Management's NVAX Position: Q1 2022 in Review

Eaton Vance Management sold out of Novavax (NVAX) in Q1 2022, closing a stake of 450 shares — an estimated $64K sold.

Eaton Vance Management first reported a position in NVAX in Q1 2016 and held it in 6 quarters. The position peaked at $117K in Q1 2016. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

Eaton Vance Management reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
Eaton Vance Management sold 450 Novavax shares in Q1 2022, an estimated $64K.
Eaton Vance Management first reported a position in Novavax in Q1 2016 and held it in 6 quarters.
Eaton Vance Management's Novavax position peaked at $117K in Q1 2016.
381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.